“Restoring Skin Barrier Function: New Treatment for Netherton Syndrome”

In Clinical Development, Featured on App, Orphan Drug Congress, Partnering & Investment by Freya SmaleJuly 22, 2015

Jean Nordstrom of Sixera Pharma AB joined us for World Orphan Drug Congress USA 2015 to present about ‘ Restoring Skin Barrier Function: New Treatment for Netherton Syndrome’ .

Download the presentation now to learn about:

Unmet medical need and market
In Vivo proof of principle
Project status and next steps
Opportunity

…and much more!

Get your copy here!

To find out more about how Sixera Pharma AB’s new treatment for Netherton Syndrome , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.

[[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates

[[Whitepaper ]] Disruptive Innovation in Rare Disease Markets

Choosing the Right Channel Strategy for Specialty Product Success

[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

“Restoring Skin Barrier Function: New Treatment for Netherton Syndrome”

Categories